|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Departments of 1Physiology, 2Biochemistry, and 3Cell Biology and Anatomy and Pediatrics, New York Medical College, Valhalla, New York; 4Department of Internal Medicine, Medical Pharmacology and Physiology and Nutritional Sciences, University of Missouri, Columbia, Missouri; 5Department of Pulmonology, Semmelweis University, Hungary; 6Laboratory of Experimental Gerontology, National Institute on Aging, National Institutes of Health, Baltimore; and 7Laboratory of Physiological Studies, Section on Oxidative Stress Tissue Injury, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, Maryland; and 8Reynolds Oklahoma Center on Aging, Department of Geriatric Medicine, University of Oklahoma Health Science Center, Oklahoma City, Oklahoma
Submitted 16 April 2009 ; accepted in final form 4 May 2009
Pathways that regulate mitochondrial biogenesis are potential therapeutic targets for the amelioration of endothelial dysfunction and vascular disease. Resveratrol was shown to impact mitochondrial function in skeletal muscle and the liver, but its role in mitochondrial biogenesis in endothelial cells remains poorly defined. The present study determined whether resveratrol induces mitochondrial biogenesis in cultured human coronary arterial endothelial cells (CAECs). In CAECs resveratrol increased mitochondrial mass and mitochondrial DNA content, upregulated protein expression of electron transport chain constituents, and induced mitochondrial biogenesis factors (proliferator-activated receptor-coactivator-1
, nuclear respiratory factor-1, mitochondrial transcription factor A). Sirtuin 1 (SIRT1) was induced, and endothelial nitric oxide (NO) synthase (eNOS) was upregulated in a SIRT1-dependent manner. Knockdown of SIRT1 (small interfering RNA) or inhibition of NO synthesis prevented resveratrol-induced mitochondrial biogenesis. In aortas of type 2 diabetic (db/db) mice impaired mitochondrial biogenesis was normalized by chronic resveratrol treatment, showing the in vivo relevance of our findings. Resveratrol increases mitochondrial content in endothelial cells via activating SIRT1. We propose that SIRT1, via a pathway that involves the upregulation of eNOS, induces mitochondrial biogenesis. Resveratrol induced mitochondrial biogenesis in the aortas of type 2 diabetic mice, suggesting the potential for new treatment approaches targeting endothelial mitochondria in metabolic diseases.
vasoprotection; histone deacetylase; endothelial dysfunction; diabetes; obesity
This article has been cited by other articles:
![]() |
J. Gracia-Sancho, G. Villarreal Jr., Y. Zhang, and G. Garcia-Cardena Activation of SIRT1 by resveratrol induces KLF2 expression conferring an endothelial vasoprotective phenotype Cardiovasc Res, November 12, 2009; (2009) cvp337v2. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Ungvari, N. Labinskyy, P. Mukhopadhyay, J. T. Pinto, Z. Bagi, P. Ballabh, C. Zhang, P. Pacher, and A. Csiszar Resveratrol attenuates mitochondrial oxidative stress in coronary arterial endothelial cells Am J Physiol Heart Circ Physiol, November 1, 2009; 297(5): H1876 - H1881. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Szabo A glass of red wine to improve mitochondrial biogenesis? Novel mechanisms of resveratrol Am J Physiol Heart Circ Physiol, July 1, 2009; 297(1): H8 - H9. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |